Patricia L Allen insider trades

Open-market stock purchases and sales by Patricia L Allen, Director at Zenas BioPharma, Inc, from SEC Form 4 filings since Dec 8, 2010.

Track record: 0% of 3 scored buys are up 5% or more since purchase, averaging -31%.

Recent trades

DateStockTradeValue
Jun 15, 2026ZBIO Zenas BioPharma, IncBought (not open market)—
Feb 13, 2026ZBIO Zenas BioPharma, IncBought$110K
Feb 12, 2026ZBIO Zenas BioPharma, IncBought$133K
Feb 12, 2026ZBIO Zenas BioPharma, IncBought$139K

Companies traded

  • ZBIO Zenas BioPharma, Inc: 3 buys, last Jun 15, 2026
  • DCPH Deciphera Pharmaceuticals, Inc: 5 sales, last Jan 16, 2024
  • YMTX Yumanity Therapeutics, Inc: other filings, last Jun 2, 2021
  • ZFGN Zafgen, Inc: 2 buys, last Jan 22, 2019
  • ALNY Alnylam Pharmaceuticals, Inc: other filings, last Dec 8, 2010

Get free alerts when Patricia L Allen files a new trade →